Follow

New Nordic Healthbrands AB

Nasdaq First North GM (Sweden)

New Nordic Healthbrands develops herbal supplements, herbal remedies, and personal care products to satisfy specific health and beauty needs. The products are sold in North America, Europe, and Asia. Some products sold are Active legs, Active Liver, Apple Cider, Chili Burn, Clear brain, Ear tone, Equazen, Frutin gastro gel, Hair Gro, Hair Volume, Kilo trim, and Melissa Dream.
New Nordic Healthbrands develops herbal supplements, herbal remedies, and personal care products to satisfy specific health and beauty needs. The products are sold in North America, Europe, and Asia. Some products sold are Active legs, Active Liver, Apple Cider, Chili Burn, Clear brain, Ear tone, Equazen, Frutin gastro gel, Hair Gro, Hair Volume, Kilo trim, and Melissa Dream.
Go to market
Read more

Sector:
CONSUMER DISCRETIONARY
>
Consumer Defensive
Packaged Foods
News
No available news yet for New Nordic Healthbrands AB
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
NNH
SE0001838038
Nasdaq First North GM
Sweden (SE)
Details of share in New Nordic Healthbrands AB with ticker NNH
Status
Active
Amount of instruments
6 195 200
Currency
SEK
First trading date
23 Jan 2007
Type
Price
Pre-money
Time
Files
IPO
56.00 SEK
316.92M SEK
08 Dec - 21 Dec 2006
IPO in New Nordic Healthbrands AB
Type
Price
Pre-money
Time
Files
Market move
2022
Listing of New Nordic Healthbrands AB on NASDAQ STOCKHOLM
People
Karl Kristian Bergman Jensen
CEO
Marinus Blåbjerg Sørensen
Chairman of the board
Jessica Tyreman
Board member
Karl Kristian Bergman Jensen
Board member
Lennart Sjölund
Board member
Company Details
Sector
CONSUMER DISCRETIONARY

Address
Södra Förstadsgatan 3
Zip code
211 43
City/district
Malmö
Country
Sweden (SE)
Registration number
556698-0453
LEI code
213800JGTLNSKRD49G44
First trade date
23 Jan 2007
Registration date
10 Feb 2006
Short name
NNH

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More